Biotech · Private company
Bavarian Nordic
Track this companyFree. Adds Bavarian Nordic to your Dealase workspace and tells you when its record changes.
Clinical trials255 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline22
- ABNCoV2Phase 3 · COVID-19 DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CHIKV VLP vaccinePhase 3 · Chikungunya VirusClinicalTrials.gov · fetched Nov 12, 2026
- CHIKV VLP vaccine boosterPhase 3 · Chikungunya Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- CHIKV VLP/adjuvantPhase 3 · Chikungunya VirusClinicalTrials.gov · fetched Nov 12, 2026
- ComirnatyPhase 3 · COVID-19 DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MVA-BN-RSV vaccinePhase 3 · Respiratory Syncytial Virus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- PXVX0200Phase 3 · CholeraClinicalTrials.gov · fetched Nov 12, 2026
- PXVX0200 Lot APhase 3 · CholeraClinicalTrials.gov · fetched Nov 12, 2026
- PXVX0200 Lot BPhase 3 · CholeraClinicalTrials.gov · fetched Nov 12, 2026
- PXVX0200 Lot CPhase 3 · CholeraClinicalTrials.gov · fetched Nov 12, 2026
- BN-Brachyury plus radiationPhase 2 · ChordomaClinicalTrials.gov · fetched Nov 12, 2026
- ChikungunyaPhase 2 · ChikungunyaClinicalTrials.gov · fetched Nov 12, 2026
- CHIKV VLP, adjuvantedPhase 2 · Chikungunya VirusClinicalTrials.gov · fetched Nov 12, 2026
- CHIKV VLP/adjuvantedPhase 2 · Chikungunya Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- CHIKV VLP/unadjuvantedPhase 2 · Chikungunya Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- JynneosPhase 2 · Monkeypox (Mpox)ClinicalTrials.gov · fetched Nov 12, 2026
- MVA-BN (Quail)Phase 2 · Monkeypox (Mpox)ClinicalTrials.gov · fetched Nov 12, 2026
- MVA-BN-WEVPhase 2 · EncephalitisClinicalTrials.gov · fetched Nov 12, 2026
- MVA-BN-EBVPhase 1 · Epstein Barr Virus (EBV) InfectionClinicalTrials.gov · fetched Nov 12, 2026
- TAEK-VAC-HerByPhase 1 · ChordomaClinicalTrials.gov · fetched Nov 12, 2026
- VAXCHORA (Cholera Vaccine, Live, Oral)Cholera (Disorder)ClinicalTrials.gov · fetched Nov 12, 2026
- VivotifTyphoid FeverClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young AdultsPHASE1 · NOT_YET_RECRUITING · started Dec 15, 2026ClinicalTrials.gov NCT07888088 · fetched Nov 12, 2026
- Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production CellsPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 27, 2025ClinicalTrials.gov NCT07199569 · fetched Nov 12, 2026
- A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 5, 2025ClinicalTrials.gov NCT07003984 · fetched Nov 12, 2026
- A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV VaccinePHASE2 · ACTIVE_NOT_RECRUITING · started Mar 10, 2025ClinicalTrials.gov NCT06899802 · fetched Nov 12, 2026
- Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster VaccinationPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 30, 2023ClinicalTrials.gov NCT06007183 · fetched Nov 12, 2026
- ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2PHASE3 · COMPLETED · started Aug 30, 2022ClinicalTrials.gov NCT05329220 · fetched Nov 12, 2026
- Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 YearsPHASE3 · COMPLETED · started May 12, 2022ClinicalTrials.gov NCT05349617 · fetched Nov 12, 2026
- MVA-BN-RSV Vaccine TrialPHASE3 · TERMINATED · started Apr 19, 2022ClinicalTrials.gov NCT05238025 · fetched Nov 12, 2026
- A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle VaccinePHASE2 · COMPLETED · started Oct 11, 2021ClinicalTrials.gov NCT05065983 · fetched Nov 12, 2026
- A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)PHASE3 · COMPLETED · started Sep 29, 2021ClinicalTrials.gov NCT05072080 · fetched Nov 12, 2026
- TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing CancerPHASE1 · COMPLETED · started Aug 10, 2020ClinicalTrials.gov NCT04246671 · fetched Nov 12, 2026
- Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)PHASE2 · COMPLETED · started Nov 20, 2019ClinicalTrials.gov NCT03992872 · fetched Nov 12, 2026
- BN Brachyury and Radiation in ChordomaPHASE2 · COMPLETED · started Oct 31, 2018ClinicalTrials.gov NCT03595228 · fetched Nov 12, 2026
- Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the CervixPHASE1_PHASE2 · TERMINATED · started Sep 27, 2018ClinicalTrials.gov NCT03610581 · fetched Nov 12, 2026
- Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic AdenocarcinomaPHASE1_PHASE2 · TERMINATED · started Aug 8, 2018ClinicalTrials.gov NCT03376659 · fetched Nov 12, 2026
- A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRCPHASE2 · TERMINATED · started Jun 26, 2018ClinicalTrials.gov NCT03547999 · fetched Nov 12, 2026
- Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy AdultsPHASE2 · COMPLETED · started Apr 18, 2018ClinicalTrials.gov NCT03483961 · fetched Nov 12, 2026
- VAXCHORA Pediatric Study to Assess Safety and ImmunogenicityPHASE4 · COMPLETED · started Jul 21, 2017ClinicalTrials.gov NCT03220737 · fetched Nov 12, 2026
- Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical ProstatectomyPHASE2 · TERMINATED · started Jul 18, 2016ClinicalTrials.gov NCT02772562 · fetched Nov 12, 2026
- Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-FiloPHASE3 · TERMINATED · started May 31, 2016ClinicalTrials.gov NCT02661464 · fetched Nov 12, 2026
- Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among TravelersCOMPLETED · started Aug 26, 2015ClinicalTrials.gov NCT02391909 · fetched Nov 12, 2026
- A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older AdultsPHASE3 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT02100631 · fetched Nov 12, 2026
- A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy AdultsPHASE3 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT02094586 · fetched Nov 12, 2026
- Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent CholeraPHASE3 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01895855 · fetched Nov 12, 2026
- Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200PHASE1 · COMPLETED · started Apr 1, 2012ClinicalTrials.gov NCT01585181 · fetched Nov 12, 2026